Novak Djokovic holds an 80% stake in a biotech firm that is developing a COVID-19 treatment, QuantBioRes CEO Ivan Loncarevic said to Reuters.
Djokovic made the acquisition in June 2020, but Loncarevic did not reveal how much he invested. Per the outlet, Djokovic holds 40.8% while his wife, Jelena, owns 39.2% of the company. Loncarevic stressed to Reuters that QuantBioRes is working on developing a treatment, not a vaccine, for COVID-19.
The 20-time major singles champion made global headlines recently after his COVID-19 controversy and visa battle ahead of the Australian Open, which resulted in his deportation.